| An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015) R Ojha, J Singh, A Ojha, H Singh, S Sharma, K Nepali Expert opinion on therapeutic patents 27 (3), 311-345, 2017 | 100 | 2017 |
| Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors S Sharma, J Singh, R Ojha, H Singh, M Kaur, PMS Bedi, K Nepali European journal of medicinal chemistry 112, 298-346, 2016 | 74 | 2016 |
| Purine analogues as kinase inhibitors: a review S Sharma, S Mehndiratta, S Kumar, J Singh, P MS Bedi, K Nepali Recent Patents on Anti-Cancer Drug Discovery 10 (3), 308-341, 2015 | 37 | 2015 |
| Synthesis of 1, 2, 3-triazole tethered bifunctional hybrids by click chemistry and their cytotoxic studies J Singh, S Sharma, AK Saxena, K Nepali, PMS Bedi Medicinal Chemistry Research 22, 3160-3169, 2013 | 30 | 2013 |
| Development and Validation of stability indicating UV-Visible spectrophotometric method for simultaneous estimation of neem (Azadirachtin) and curcumin in pharmaceutical tablet … D Sharma, P Kaur, G Singh, D Singh, S Verma, J Singh Analytical Chemistry Letters 9 (4), 564-581, 2019 | 18 | 2019 |
| Structure activity relationship of arylidene pyrrolo and pyrido [2, 1-b] quinazolones as cytotoxic agents: synthesis, SAR studies, biological evaluation and docking studies V Mangla, K Nepali, G Singh, J Singh, S Guru, MK Gupta, P Mahajan, ... Medicinal Chemistry 9 (5), 642-650, 2013 | 16 | 2013 |
| Tailored quinolines demonstrate flexibility to exert antitumor effects through varied mechanisms-a medicinal perspective S Sharma, A Singh, S Sharma, R Sharma, J Singh, N Kinarivala, K Nepali, ... Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 21 (3), 288-315, 2021 | 6 | 2021 |